Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
A "human papillomavirus-infected cell" refers specifically to a basal epithelial cell harboring replicating HPV genomes. These infected cells serve as reservoirs for viral persistence and propagation. Depending on host factors and specific viral genotype(s), they may remain clinically silent or progress toward benign hyperplasia or malignant transformation due to disruption of key tumor suppressor pathways.
Varies depending on the drug. Examples include: Inhibition of viral DNA polymerase (Cidofovir), immune stimulation (Imiquimod), cytotoxic effects (Podophyllin/Podofilox), prevention of infection (Vaccines).
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Human Papillomavirus-Infected Cell (HPV-Infected Cell).